Teva announces launch of generic EXJADEŽ (deferasirox) tablets in the U.S.
Teva announced the launch of a generic version of EXJADEŽ1 (deferasirox) Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg, in the U.S. Deferasirox Tablets for Oral Suspension are an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions. March 22, 2019